Recording of M4K Pharma’s Scientific Update Meeting – November 6th, 2019

By | 2019-11-26T16:22:38+00:00 November 26th, 2019|

Listen to a recording of the Nov 2019 Monthly Scientific Meeting Listen to M4K Pharma's Scientific Update Meeting from November 6th, 2019 where our scientists and collaborators discuss the latest progress in our Medicines4Kids project for a deadly children's brain cancer called DIPG. Join us to hear first-hand how we are developing [...]

In the News: Six-year-old’s death leads to hope of new drug for childhood cancer

By | 2019-10-30T12:31:12+00:00 October 21st, 2019|

Our collaborator Dr Chris Jones and his fantastic team at The Institute of Cancer Research were profiled in The Observer for their work on DIPG with support from Abbie's Army. M4K Pharma is proud to be working with them to bring an affordable DIPG cure to patients.  

SGC-Oxford team comes out in support of Brain Tumour Charity’s Twilight Walk

By | 2019-10-03T11:45:04+00:00 October 1st, 2019|

SGC-Oxford team comes out in support of Brain Tumour Charity's Twilight Walk On September 29th 2019, the Brain Tumour Charity organized The Twilight Walk in Warwick, UK, to raise funds for research and patient support. M4K Pharma's DIPG project collaborators at the Structural Genomics Consortium (SGC)- University of Oxford took part in the event by [...]

Fostering open collaboration in drug development for paediatric brain tumours

By | 2019-10-01T14:11:13+00:00 September 25th, 2019|

Fostering open collaboration in drug development for paediatric brain tumours Wong et al. describe in Biochemical Society Transactions how open collaboration and an open drug discovery model, like the one used by M4K Pharma, can help overcome the challenges faced while researching therapies for rare paediatric brain tumours such as DIPG.  Prognosis of childhood brain [...]

Recording of M4K Pharma’s Scientific Update Meeting – August 7th, 2019

By | 2019-09-05T10:20:36+00:00 August 20th, 2019|

Listen to a recording of the August 2019 Monthly Scientific Meeting Listen to M4K Pharma's Scientific Update Meeting from August 7th, 2019 where our scientists and collaborators discussed the latest progress in our Medicines4Kids project for a deadly children's brain cancer called DIPG. Everyone is invited to hear first-hand how we are [...]

Study published on new drug class targeting ACVR1 mutation for DIPG

By | 2019-05-16T15:20:11+00:00 May 9th, 2019|

Study published on new drug class targeting ACVR1 mutation for DIPG Scientists at The Institute of Cancer Research, London, along with colleagues at the Structural Genomics Consortium in Oxford, have published their findings on a new drug class that can kill brain cancer cells with mutations in the ACVR1 gene and shrink tumours in mice. Mutated versions [...]

Recording of M4K Pharma’s Scientific Update Meeting – April 24th, 2019

By | 2019-05-16T15:09:52+00:00 April 29th, 2019|

Listen to a recording of the April 24th 2019 Scientific Update Meeting Listen to our scientists and collaborators discuss the latest progress in M4K Pharma’s quest for a medicine for DIPG- a deadly children’s brain cancer. Everyone is invited to dial-in and join our live meetings. To find out when our next [...]

Recording of M4K Pharma’s Scientific Update Meeting – March 6th, 2019

By | 2019-03-20T21:47:26+00:00 March 15th, 2019|

Recording of M4K Pharma’s Scientific Update Meeting – March 6th, 2019 Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- a deadly children's brain cancer. Everyone is invited to dial-in and join our live meetings. To find out when our next meeting will be, follow [...]

Recording of M4K Pharma’s Scientific Update Meeting – December 4th, 2018.

By | 2018-12-07T21:20:51+00:00 December 7th, 2018|

Recording of M4K Pharma's Scientific Update Meeting - December 4th, 2018 Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- a deadly children's brain cancer. In this meeting, the team provides a comprehensive summary of the project accomplishments at the one year [...]

Can an open drug discovery model find a solution for rare brain cancers in children?

By | 2018-08-03T11:45:44+00:00 August 1st, 2018|

Can an open drug discovery model find a solution for rare brain cancers in children? Dr. Aled Edwards OICR-funded drug discovery project’s unique ‘open science’ business model is accelerating the search for a solution to lethal pediatric brain cancers. Diffuse intrinsic pontine glioma (DIPG) is a lethal and inoperable brain cancer with a median survival [...]